© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. ATLAS CAPITAL ADVISORS LLC is the top corporate investor, holding 40K shares valued at $36.40K. A 0.16% stake in Decibel Therapeutics, Inc. is owned by the company. JPMORGAN CHASE & CO owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the DBTX insiders holding of N/A of the stake in company, FOY MATTHEW, , holds the largest shares of 1.18M. GLAXOSMITHKLINE PLC, director, is the second largest DBTX insider with ownership of 1.18M shares. CASDIN PARTNERS MASTER FUND, L.P., 10 percent owner, stands third with possession of 1.12M shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own DBTX shares is N/A, representing N/A of the company's common stock.
JPMORGAN CHASE & CO, in the last quarter, reduced its stake in DBTX by -100% restricting it's holding to 0 shares of worth nearly -. WELLS FARGO & COMPANY/MN also lessened -100% of the DBTX shares from its portfolio, reducing its holding to 0 shares of worth -. NORTHERN TRUST CORP also shunned DBTX shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, ATLAS CAPITAL ADVISORS LLC increased its stake in DBTX by 60% in the last quarter. The institutional holder raised its holding to 40 thousand shares having worth more than $36.40K. N/A also added N/A more shares of DBTX to its portfolio, raising its holding to - shares of worth -. N/A also increased its DBTX shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in DBTX is Foy Matthew , at the company. Additionally, DBTX stock is highly held by director GLAXOSMITHKLINE PLC and 10 percent owner Casdin Partners Master Fund, L.P. among others.
Company executives, directors, and other insiders own N/A percent of Decibel Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which DBTX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include TRASK ANNA.
There have been 0 transaction(s) during the past 6-months in which Decibel Therapeutics, Inc. insiders have bought stock, totalling 0 shares
Around 0 Decibel Therapeutics, Inc. shares are held by insiders, which represents about N/A of DBTX stock.
DBTX , Foy Matthew holds the largest portfolio of the company's shares. DBTX shares owned by Foy total nearly 1.18 million.
ATLAS CAPITAL ADVISORS LLC is the largest institutional owner in DBTX which holds 40 thousand shares worth $36.40K or 0.16% of the total DBTX shares outstanding followed by JPMORGAN CHASE & CO with ownership of 0 shares representing 0% of the DBTX ownership. WELLS FARGO & COMPANY/MN is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the DBTX is concerned, it is a stock which is optionable.
Number of DBTX shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, N/A shares of DBTX are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, DBTX has N/A shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for DBTX is N/A.